Late-Onset MS: Disease Course and Safety-Efficacy of DMTS.

Buscarinu, Maria Chiara; Reniè, Roberta; Morena, Emanuele; Romano, Carmela; Bellucci, Gianmarco; Marrone, Antonio; Bigi, Rachele; Salvetti, Marco; Ristori, Giovanni

Buscarinu, Maria Chiara; Reniè, Roberta; Morena, Emanuele; Romano, Carmela; Bellucci, Gianmarco; Marrone, Antonio; Bigi, Rachele; Salvetti, Marco; Ristori, Giovanni.

Afiliación

Buscarinu MC; Department of Neuroscience, Mental Health, and Sensory Organs, Sapienza University, Rome, Italy.
Reniè R; Neuroimmunology Unit, IRCCS Fondazione Santa Lucia, Rome, Italy.
Morena E; Department of Clinical-Experimental Neuroscience and Psychiatry, Sapienza University, Rome, Italy.
Romano C; Department of Neuroscience, Mental Health, and Sensory Organs, Sapienza University, Rome, Italy.
Bellucci G; Department of Clinical-Experimental Neuroscience and Psychiatry, Sapienza University, Rome, Italy.
Marrone A; Department of Neuroscience, Mental Health, and Sensory Organs, Sapienza University, Rome, Italy.
Bigi R; Department of Neuroscience, Mental Health, and Sensory Organs, Sapienza University, Rome, Italy.
Salvetti M; Department of Neuroscience, Mental Health, and Sensory Organs, Sapienza University, Rome, Italy.
Ristori G; Department of Neuroscience, Mental Health, and Sensory Organs, Sapienza University, Rome, Italy.

Front Neurol ; 13: 829331, 2022.

Article en En | MEDLINE | ID: mdl-35356454

Palabras clave

disease modifying therapies; efficacy; immunosenescence; late onset multiple sclerosis; safety

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google